Research groups
Colleges
Ali Kay
- Primary Investigator - Making it personal: using theatre to explore the implications of genomics for pregnancy (University of Oxford PCER Fund)
- Co-investigator - iPREGCARE study: implications of genomic reproductive recurrence risk assessment for de novo mutations (NIHR; PI: Prof. Anne Goriely)
- Research Fellow (JRF), Oxford Centre for Personalised Medicine & St. Anne's College
Research areas: genetics, genomics & genetic counselling; psychology; social science approaches to healthcare and medicine; qualitative research; PPIE.
Dr. Alison Kay (Ali) is an interdisciplinary researcher investigating experiences and implications of reproductive personalised medicine for practitioners, patients and families. She is also interested in the intersection of shifting public understandings of genetics with perspectives on the family, and the implications of new genomic technologies such as Direct-to-Consumer Genetic Testing (DTC-GT) for identity and health.
Ali is able to draw on her ten years' experience in rare disease patient/public advocacy to drive innovative public involvement and engagement in research.
Doctorate (DPhil). Nuffield College, Oxford
MSc: Genetic & Genomic Counselling, Cardiff University; MSc Psychology, UCLan
MA (Hons) University of Edinburgh; PGCE (DMU)
Recent publications
-
Professionals' views on providing personalized recurrence risks for de novo mutations: Implications for genetic counseling
Kay AC. et al, (2024), Journal of Genetic Counseling
-
Providing recurrence risk counselling for parents after diagnosis of a serious genetic condition caused by an apparently de novo mutation in their child: a qualitative investigation of the PREGCARE strategy with UK clinical genetics practitioners.
Kay AC. et al, (2023), J Med Genet, 60, 925 - 931
-
Adoptees' views and experiences of direct-to-consumer (DTC) genomic testing: an exploratory interview study from the UK.
Kay AC. and Taverner NV., (2023), J Community Genet, 14, 149 - 162